Acasti Pharma Inc (ACST)
2.90
-0.03
(-0.97%)
USD |
NASDAQ |
Apr 26, 16:00
2.92
+0.02
(+0.69%)
Pre-Market: 20:00
Acasti Pharma Total Assets (Quarterly): 76.18M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 76.18M |
| September 30, 2023 | 78.21M |
| June 30, 2023 | 73.03M |
| March 31, 2023 | 79.12M |
| December 31, 2022 | 116.80M |
| September 30, 2022 | 120.91M |
| June 30, 2022 | 124.93M |
| March 31, 2022 | 128.62M |
| December 31, 2021 | 114.23M |
| September 30, 2021 | 119.80M |
| June 30, 2021 | 60.45M |
| March 31, 2021 | 62.46M |
| December 31, 2020 | 30.30M |
| September 30, 2020 | 13.83M |
| June 30, 2020 | 20.14M |
| March 31, 2020 | 22.85M |
| December 31, 2019 | 29.76M |
| September 30, 2019 | 28.58M |
| June 30, 2019 | 29.36M |
| March 31, 2019 | 36.90M |
| December 31, 2018 | 43.80M |
| September 30, 2018 | 15.42M |
| June 30, 2018 | 20.46M |
| March 31, 2018 | 17.78M |
| December 31, 2017 | 21.81M |
| Date | Value |
|---|---|
| September 30, 2017 | 15.93M |
| June 30, 2017 | 17.32M |
| November 30, 2016 | 16.07M |
| August 31, 2016 | 17.99M |
| May 31, 2016 | 19.74M |
| February 29, 2016 | 21.04M |
| November 30, 2015 | 23.13M |
| August 31, 2015 | 24.94M |
| May 31, 2015 | 28.29M |
| February 28, 2015 | 29.74M |
| November 30, 2014 | 34.05M |
| August 31, 2014 | 38.04M |
| May 31, 2014 | 40.39M |
| February 28, 2014 | 41.01M |
| November 30, 2013 | 24.02M |
| August 31, 2013 | 24.54M |
| May 31, 2013 | 10.99M |
| February 28, 2013 | 11.89M |
| November 30, 2012 | 13.18M |
| August 31, 2012 | 13.75M |
| May 31, 2012 | 14.67M |
| February 29, 2012 | 15.82M |
| November 30, 2011 | 14.23M |
| August 31, 2011 | 10.32M |
| May 31, 2011 | 10.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
13.83M
Minimum
Sep 2020
128.62M
Maximum
Mar 2022
69.98M
Average
73.03M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 7.832M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 964.80M |
| ESSA Pharma Inc | 144.49M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.50M |
| Shareholders Equity (Quarterly) | 64.68M |